In preclinical models, significant inhibition of HNSCC tumour growth by COX-2 blockade using CXB has previously been reported24; also, we had in vitro findings detected by PCNA, Ki-67 and p-ERK1/2 in OSCC cells. The gene discussed is MAPK3; the disease is neoplasm.